Last month, the Biden administration announced it would allow Medicare to negotiate drug prices, prompting right-wing hysteria about price controls. Yet Biden's plans don’t go far enough: the state should fund R&D to further cut costs.
  • theodewere@kbin.social
    9·
    10 months ago

    any chode who argues that drug prices need to be high to fund research is just a chode being a chode

    the Biden administration announced the list of ten drugs over whose price Medicare would, for the first time, negotiate, under new authority granted by the Inflation Reduction Act last year

    this is huge news that the drug companies hate

    Big Pharma, unsurprisingly, is fighting against the Biden administration’s efforts, launching lawsuits to block the new rules. Meanwhile, writers at the Economist — also unsurprisingly — have come to the aid of Big Pharma in its hour of need. While conceding that Americans do spend too much on drugs, the “newspaper” nonetheless complains that the new “heavy handed” rules “have swung from one extreme to the other.”

    and their friends are trying to help them, showing just how reactionary they are to anything that helps patients, by calling negotiation “extreme”… free market is just too scary for these guys i guess…

    naturally Big Pharma hopes to get their lawsuits straight onto the Supreme Court docket, where their friends will issue a ruling written by Pfizer